Stanford A型急性主动脉综合征中应用「分支优先」技术行主动脉弓替换是否安全?
本文为心脏外科最佳证据主题,按结构化方案检索到64篇论文,其中10篇为回答临床问题的最佳证据。所有纳入论文报告的死亡率和/或神经系统结局与当前传统修复标准相比可接受。作者结论:虽需更大样本、直接比较和长期随访,但「分支优先」技术在急性主动脉综合征中已在多个中心安全实施,死亡率和神经系统结局及中期生存可接受。
要点
- 10篇最佳证据论文均报告「分支优先」技术行主动脉弓替换的死亡率和/或神经系统结局与传统修复标准相比可接受。
- 作者结论认为该技术在急性主动脉综合征中已在多个中心安全实施,中期生存可接受。
- 作者指出仍需更大样本、直接比较和长期随访。
核心结论
- 「分支优先」技术行主动脉弓替换在急性主动脉综合征中已在多个中心安全实施,死亡率和神经系统结局及中期生存可接受,但仍需更大样本、直接比较和长期随访。
研究设计与样本
- 心脏外科最佳证据主题,按结构化方案检索到64篇论文,其中10篇代表回答临床问题的最佳证据。
主要发现
- 所有纳入论文报告的死亡率和/或神经系统结局与当前传统修复标准相比可接受。
局限性
- 原文指出需要更大样本、直接比较和长期随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: 'Can a "branch-first" approach to aortic arch replacement be safely utilized in Stanford type A acute aortic syndromes?' Altogether 64 papers were found using the reported searches, of which 10represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. All papers included in this BET reported acceptable mortality and/or neurological outcomes in comparison to currently published standards for traditional repair. We conclude that while there is a need for larger series, direct comparison and long-term follow-up, the 'branch-first' approach to aortic arch replacement has been safely performed in several centres in the setting of acute aortic syndromes with results demonstrating acceptable mortality, neurological outcomes and mid-term survival.
引用
- Kemp U, Zhu A. Can a 'branch-first' approach to aortic arch replacement be safely utilized in Stanford type A acute aortic syndromes? Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37897666. doi:10.1093/icvts/ivad172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。